Trending stocks today
Evome Medical Technologies (EVMT-X)
CVE:EVMT
0.10
Financials
Technical Analysis
This summary was created by AI, based on 1 opinions in the last 12 months.
Evome Medical Technologies (EVMT-X) formerly known as Salona Global Medical (SGMD-X) had an acquisition strategy in physiotherapy that led to a fair amount of debt, causing concern in the market. The new management is focused on paying down debt by selling off divisions and aims to eliminate all acquisition debt by late 2024/early 2025. The company has introduced new technology that has made its equipment smaller and more tech-driven, enabling mass sales. With revenue ramping up and positive EBITDA, the company is looking to expand its deals globally, flying under the radar in the market.
N/A
Unknown
- «
- ‹
- 1
- ›
- »
Evome Medical Technologies(EVMT-X) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Evome Medical Technologies(EVMT-X) Frequently Asked Questions
What is Evome Medical Technologies stock symbol?
Evome Medical Technologies is a Canadian stock, trading under the symbol EVMT-X on the TSX Venture Exchange (EVMT-CV). It is usually referred to as TSXV:EVMT or EVMT-X
Is Evome Medical Technologies a buy or a sell?
In the last year, there was no coverage of Evome Medical Technologies published on Stockchase.
Is Evome Medical Technologies a good investment or a top pick?
Evome Medical Technologies was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Evome Medical Technologies.
Why is Evome Medical Technologies stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Evome Medical Technologies worth watching?
In the last year, there was no coverage of Evome Medical Technologies published on Stockchase.
What is Evome Medical Technologies stock price?
On 2024-12-13, Evome Medical Technologies (EVMT-X) stock closed at a price of $0.095.
(Formerly Salona Global Medical, SGMD-X)
Acquisition strategy in physiotherapy, racked up a fair bit of debt. Market got concerned. New management, paying down some debt by selling off divisions. Goal is to get rid of all acquisition debt by late 2024/early 2025. New tech has made equipment smaller and more technology-driven, which will allow for mass sales.
Revenue ramping up, EBITDA has turned positive. Under the radar. Looking to do deals outside NA as well.